Latest HIV Test for Pregnancy Screening in Kathmandu Protect the Mother, Protect the Baby

HIV Testing in Pregnancy: A Preventable Tragedy

HIV testing during pregnancy is one of the most important preventive interventions in modern medicine. Without treatment, a pregnant woman living with HIV has a 15 to 45 percent chance of transmitting the virus to her baby during pregnancy, delivery or breastfeeding. With antiretroviral therapy started early in pregnancy and continued through delivery and breastfeeding, that risk drops to below 1 percent in many settings — one of the most dramatic risk reductions achievable in all of medicine.

The reason this matters so much is that mother-to-child transmission is entirely preventable. The virus does not have to pass from mother to baby — effective treatment suppresses the viral load to undetectable levels, and the baby is born protected. This is not a theoretical benefit; it is a routine intervention that has prevented thousands of infant HIV infections globally.

In Nepal, HIV testing in pregnancy is recommended as routine antenatal care, yet coverage varies between facilities and many women are not tested early enough for treatment to be fully effective. Late diagnosis — in the third trimester or at delivery — limits the time available for viral suppression and increases transmission risk.

This page explains when and how HIV testing is done in pregnancy, what the different test types measure, how antiretroviral treatment prevents transmission, what happens after a positive result, and how Thamel Clinic supports pregnant women through confidential antenatal HIV care in Kathmandu.

When to Test During Pregnancy

The recommended timing for HIV testing in pregnancy is as early as possible — ideally at the first antenatal visit, typically in the first trimester. Early testing allows the maximum time for antiretroviral therapy to suppress the viral load before delivery, which is the single most important factor in preventing transmission.

For women who test negative early in pregnancy but have ongoing risk factors — multiple partners, partner with unknown status, or recent unprotected sex — repeat testing in the third trimester is recommended. HIV can be acquired during pregnancy, and a negative first-trimester test does not guarantee a negative result at delivery.

For women who present late to antenatal care or who have not been tested at all, testing should happen as soon as possible — even in the third trimester or at delivery. Every week of treatment before delivery reduces transmission risk, so late testing is far better than no testing.

• Test at the first antenatal visit — ideally first trimester.
• Repeat testing in third trimester if risk factors are present.
• Late presenters should test immediately — even in third trimester.
• Test at delivery if never tested during pregnancy.
• Postpartum testing is recommended if status is unknown.
• Earlier treatment = lower transmission risk.

HIV Test Types for Pregnancy

The standard HIV test in pregnancy is the fourth-generation antigen-antibody combination test, which detects both HIV antibodies and the p24 antigen. This test can detect infection earlier than antibody-only tests — typically within two to four weeks of exposure — making it ideal for antenatal screening where early detection maximizes treatment time.

Rapid HIV tests provide results in 15 to 30 minutes and are useful for women who present late or at delivery when time is limited. A reactive rapid test requires confirmatory testing, but it allows immediate initiation of treatment while confirmation is pending — critical when every day counts for viral suppression.

For women with known HIV-positive status, viral load testing monitors treatment effectiveness. An undetectable viral load — typically below 50 copies per milliliter — is the goal because it means the virus cannot be transmitted to the baby. Regular viral load monitoring during pregnancy ensures treatment is working.

• 4th-generation combo test: detects antibodies + p24 antigen, earliest detection.
• Rapid tests: 15–30 minute results, useful for late presenters.
• Reactive rapid test needs confirmatory testing but allows immediate treatment.
• Viral load monitoring confirms treatment effectiveness.
• Undetectable viral load = no transmission risk to baby.
• All test types are safe in pregnancy — no risk to the fetus.

ART and Preventing Mother-to-Child Transmission

Antiretroviral therapy — ART — is the cornerstone of preventing mother-to-child transmission. Women living with HIV are started on ART as early in pregnancy as possible, typically a combination of three antiretroviral drugs. The goal is to suppress the viral load to undetectable levels before delivery.

When the viral load is undetectable — generally below 50 copies per milliliter — the risk of transmission during pregnancy and delivery approaches zero. Even when viral load is not fully suppressed, every reduction in viral load reduces transmission risk. ART is safe in pregnancy and is the standard of care worldwide.

Additional measures complete the prevention strategy: elective caesarean section may be considered when viral load is high near delivery, the baby receives antiretroviral prophylaxis after birth, and infant HIV testing is done at specific intervals — typically at birth, 6 weeks, and 18 months — to confirm the baby is uninfected.

• ART started early in pregnancy suppresses viral load.
• Undetectable viral load = near-zero transmission risk.
• Every viral load reduction reduces transmission risk.
• ART is safe in pregnancy — standard of care worldwide.
• Baby receives antiretroviral prophylaxis after birth.
• Infant testing at birth, 6 weeks and 18 months confirms status.

What Happens After a Positive Result

A positive HIV test in pregnancy is followed immediately by confirmatory testing and a referral to an ART clinic or HIV specialist. Starting treatment as soon as possible — ideally within days — is critical because every week of viral suppression before delivery reduces transmission risk. The woman is not alone; multidisciplinary care teams support her through pregnancy and postpartum.

The partner should be offered testing and counselling — if the partner is negative, pre-exposure prophylaxis (PrEP) may be recommended to prevent transmission. If the partner is positive, they should also be on treatment. This protects both the mother's health and prevents further transmission in the family.

Psychological support is essential. An HIV diagnosis in pregnancy carries significant emotional weight — fear for the baby's health, stigma concerns, and anxiety about the future. Counselling, peer support groups and mental health services are part of comprehensive care. With treatment, most women living with HIV have healthy pregnancies and HIV-negative babies.

• Confirmatory testing follows a reactive screening test.
• ART starts as soon as possible — ideally within days.
• Partner testing and counselling are recommended.
• PrEP may be offered to HIV-negative partners.
• Psychological support and counselling are part of care.
• Most women with HIV have healthy pregnancies and HIV-negative babies.

Breastfeeding and Infant Care

In Nepal, breastfeeding is the cultural norm and provides important nutrition and immunity for infants. For women living with HIV who are on effective ART with undetectable viral load, breastfeeding can be considered with careful counselling — the risk of transmission through breast milk is low when viral load is suppressed, but it is not zero.

The decision about breastfeeding is individual and depends on viral load, access to formula, and family circumstances. Women with detectable viral load should not breastfeed until suppression is achieved. Infant antiretroviral prophylaxis during breastfeeding further reduces transmission risk.

The baby of an HIV-positive mother receives antiretroviral prophylaxis after birth and is tested for HIV at specific intervals — typically at birth, 6 weeks, and 18 months — to confirm the baby is uninfected. Early infant diagnosis is critical because treatment is most effective when started early.

• Breastfeeding with undetectable viral load may be considered with counselling.
• Detectable viral load = avoid breastfeeding until suppressed.
• Infant prophylaxis during breastfeeding reduces transmission risk.
• Baby receives antiretroviral prophylaxis after birth.
• Infant HIV testing at birth, 6 weeks and 18 months.
• Early diagnosis allows early treatment if needed.

Antenatal HIV Testing & Costs

Indicative NPR pricing at Thamel Clinic. ART medication costs vary by program; government programs may provide free or subsidized treatment.

Related Services & Guides